Mr Abdalla Ali

PhD Student
Department of Microbiology and Immunology
University of Melbourne

Research Activities

One approach toward eliminating HIV latency is the activation of HIV viral production by latency reversal agents (LRAs) to induce virus mediated cytolysis or clearance through immune recognition (often called “shock and kill”). However, currently available LRAs are not specific for HIV, have off target effects and lack sufficient potency to eliminate infected T- cells. Nanoparticle delivery systems possess several advantages over more traditional drug delivery methods, and could potentially increase potency and reduce toxicity. However, there are challenges for uptake of nanoparticles in non-phagocytic resting T‐cells, the major reservoir of latent HIV.


Cell culture, flow cytometry, confocal microscopy, nanoparticles fabrication, PCR

Disease Models

HIV latency

Upcoming Events

  • Sep 29

    2020 International HBV Meeting

    Sheraton Centre Toronto Hotel MORE INFO
  • Oct 8

    2020 ISV Annual Congress

  • Oct 12

    VIIN Young Investigator Symposium Series 2020